News

But Meads and Eggington are veterans at this kind of challenge. Together they’ve created for Lamb’s the musical revue ...
Vanda Pharmaceuticals is suing the FDA again, this time alleging the agency is unlawfully delaying a hearing to discuss the rejection of the biotech's stomach disorder drug last year. The FDA has ...
Highlights include jewels from the Royal collection including Princess Margaret’s diamond rose brooch and the Williamson brooch featuring a rare pink diamond that Queen Elizabeth II commissioned in ...
What do Rihanna, the Maharaja of Patiala, King Charles, and Snow White have in common? They all have a sparkling Cartier piece in their wardrobes. Except, perhaps, Snow White, who played muse—with her ...
WASHINGTON, March 31, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced that a New Drug Application (NDA) was submitted to the U.S. Food and Drug ...
FDA rejected Vanda's Tradipitant NDA, citing insufficient efficacy data from clinical trials and long-term safety concerns. Vanda must address deficiencies, conduct two new trials, and provide ...
(Reuters) -Vanda Pharmaceuticals on Monday rejected UK-based Cycle Pharmaceuticals' second takeover proposal, which values the drugmaker at $8 per share despite a drop in Vanda's stock following ...
Oct 14 (Reuters) - Vanda Pharmaceuticals (VNDA.O), opens new tab on Monday rejected UK-based Cycle Pharmaceuticals' second takeover proposal, which values the drugmaker at $8 per share despite a ...
Vanda Pharmaceuticals has failed to persuade the FDA to approve its gastroparesis candidate on the strength of a phase 3 trial that missed its primary endpoint. The biotech came out swinging after ...
Despite failing its primary endpoint in gastroparesis, Vanda is still pushing for regulatory approval for tradipitant, facing regulatory hurdles. Despite receiving two acquisition offers with a ...
A series of increasing buyout offers has failed to convince Vanda's board of directors that the company should sell itself. After receiving "unsolicited" buyout proposals from Michigan-based CDMO ...
Vanda confirmed it received several unsolicited acquisition offers from Future Pak. The company's board rejected these proposals, stating that Vanda is worth more than the offered price. Vanda ...